Read today’s Kaiser Health News
About Covid-19
CDC, its advisers quietly expand access to Covid-19 shot for pregnant women: The CDC’s Advisory Committee on Immunization Practices voted in September to advise that adults get the Covid-19 shot through shared clinical decisionmaking between patients and providers. It did not specifically vote on whether the shot should be administered during pregnancy, yet the vote appears to encompass pregnant women, according to an update this month on the CDC website that reflects the new guidance.
About pharma
Novo buying Akero and its MASH hopeful for $4.7B upfront: Novo Nordisk is splashing out $4.7 billion in cash upfront to buy Akero Therapeutics and its experimental metabolic dysfunction-associated steatohepatitis (MASH) treatment, the FGF21 analogue efruxifermin. The deal announced Thursday also includes a contingent value right (CVR) worth around $500 million linked to US approval of efruxifermin, which is in late-stage development.
About healthcare personnel
A new model to measure nursing’s economic value: Researchers from the Johns Hopkins University School of Nursing in Baltimore and Marquette University College of Nursing in Milwaukee introduced the Nursing Human Capital Value Model Oct. 7, during a preview event for the American Nurses Enterprise’s annual Research Symposium…
Historically, investments in nurses’ education, training and work environment have been viewed primarily as costs. Nurse leaders say the new model is meant to shift that perspective by demonstrating how nursing investments can drive better care and revenue growth.